Sandoz CEO criticizes proposal for a Europe-wide list price for new medicines, saying it won't address global pricing issues. He highlights high drug prices in the U.S. and advocates for U.S. price reform to ensure patient access to innovative medicines.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing